Study Overview
Details
NCTId: NCT02467647
Status: Unknown status
Condition: Multiple Myeloma
Study Type: Interventional
Sponsor: Wuhan University
Study Description
Brief
To investigate the efficacy of the combination of Thalidomide and Huang-Lian-Jie-Du-Tang on the patients with multiple myeloma in maintain therapy.
Eligibility
Criteria:
Inclusion Criteria:
patients can take HLJDT
Exclusion Criteria:
patients can not take HLJDT
Healthy Volunteers: No
Gender: All
Min Age: 20 Years
Max Age: 85 Years
Contacts
Wuhan University
Recruiting
Wuhan
Hubei
430071
China
Shangqin Liu, Ph.D
Contact
86-27-67812781
